Development Level

Tbio 22 | 11,651
Tchem 7 | 1,388
Tclin 3 | 612
Tdark 1 | 6,593

Collection

GPCR: IDG Consortium (Targets) 2 | 126
RFA-RM-18-021 2 | 328

IMPC Phenotype

decreased total body fat amoun... 3 | 207
decreased vertical activity 2 | 208
impaired glucose tolerance 2 | 75
increased startle reflex 2 | 112
preweaning lethality, complete... 2 | 979
abnormal behavior 1 | 298
abnormal heart morphology 1 | 162
abnormal kidney morphology 1 | 65
abnormal seminal vesicle morph... 1 | 114
abnormal testis morphology 1 | 43
cardiovascular system phenotyp... 1 | 36
decreased blood urea nitrogen ... 1 | 51
decreased bone mineral density 1 | 126
decreased circulating choleste... 1 | 93
decreased circulating glucose ... 1 | 126
decreased circulating serum al... 1 | 82
decreased mean corpuscular vol... 1 | 79
decreased prepulse inhibition 1 | 82
enlarged heart 1 | 210
enlarged kidney 1 | 14
increased circulating HDL chol... 1 | 80
increased circulating alanine ... 1 | 13
increased circulating alkaline... 1 | 122
increased circulating aspartat... 1 | 15
increased circulating choleste... 1 | 66
increased circulating sodium l... 1 | 71
increased circulating triglyce... 1 | 42
increased heart weight 1 | 62
increased lactate dehydrogenas... 1 | 3
increased lean body mass 1 | 172
increased mean corpuscular hem... 1 | 96
male infertility 1 | 123
small testis 1 | 58
thrombocytopenia 1 | 56

Disease

Carcinoma 16 | 11,493
medulloblastoma, large-cell 14 | 6,241
osteosarcoma 13 | 7,950
glioblastoma 12 | 5,792
psoriasis 12 | 6,694
adult high grade glioma 11 | 3,801
diabetes mellitus 10 | 1,728
ovarian cancer 10 | 8,520
ulcerative colitis 10 | 1,819
atypical teratoid / rhabdoid tumor 9 | 5,112
Breast cancer 8 | 3,578
astrocytic glioma 8 | 2,597
ependymoma 8 | 4,679
intraductal papillary-mucinous adenoma (IPMA) 8 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,989
malignant mesothelioma 8 | 3,232
oligodendroglioma 8 | 2,850
primitive neuroectodermal tumor 8 | 3,035
Astrocytoma, Pilocytic 7 | 3,081
intraductal papillary-mucinous neoplasm (IPMN) 7 | 3,291
lung cancer 7 | 4,740
lung carcinoma 7 | 2,843
Cancer 6 | 2,499
Schizophrenia 6 | 1,160
non-small cell lung cancer 6 | 2,890
tuberculosis 6 | 2,010
Berylliosis 5 | 28
Diffuse cutaneous systemic sclerosis 5 | 17
Liver disease 5 | 237
Multiple Sclerosis, Susceptibility to 5 | 15
Narcolepsy 5 | 72
Narcolepsy-cataplexy 5 | 21
Obesity 5 | 678
Pick disease 5 | 1,894
Rheumatoid Arthritis, Systemic Juvenile 5 | 16
Rheumatoid arthritis 5 | 1,191
Sarcoidosis 1 5 | 14
Systemic lupus erythematosus 5 | 194
cystic fibrosis 5 | 1,696
follicular lymphoma 5 | 20
limited scleroderma 5 | 19
lung adenocarcinoma 5 | 2,716
non primary Sjogren syndrome sicca 5 | 891
pancreatic ductal adenocarcinoma liver metastasis 5 | 1,962
sarcoidosis 5 | 370
Autosomal recessive predisposition 4 | 1,442
Bipolar Disorder 4 | 666
Hypertension 4 | 396
Seizures 4 | 596
active Crohn's disease 4 | 922
astrocytoma 4 | 1,146
colon cancer 4 | 1,478
cutaneous lupus erythematosus 4 | 1,057
group 3 medulloblastoma 4 | 4,104
group 4 medulloblastoma 4 | 1,855
interstitial cystitis 4 | 2,312
pancreatic cancer 4 | 2,398
subependymal giant cell astrocytoma 4 | 2,287
Addison's disease 3 | 31
Atopic dermatitis 3 | 952
Bradycardia 3 | 36
Constipation 3 | 181
Depressive disorder 3 | 409
Epilepsy 3 | 792
Heart failure 3 | 162
Hyperglycemia 3 | 137
Hypoglycemia 3 | 152
Juvenile rheumatoid arthritis 3 | 111
Major Depressive Disorder 3 | 301
Melanoma 3 | 711
Multiple Sclerosis 3 | 540
Pancreatitis 3 | 123
Prostatic Neoplasms 3 | 495
Unipolar Depression 3 | 250
Weight decreased 3 | 103
breast carcinoma 3 | 1,638
dermatomyositis 3 | 966
esophageal adenocarcinoma 3 | 737
invasive ductal carcinoma 3 | 2,951
maturity-onset diabetes of the young 3 | 32
Acromegaly 2 | 51
Adenoma 2 | 167
Alzheimer's disease 2 | 658
Cholestasis 2 | 155
Cocaine-Related Disorders 2 | 92
Diabetes Mellitus, Non-Insulin-Dependent 2 | 145
Diabetes Mellitus, Type 2 2 | 142
Failure to gain weight 2 | 365
Hypersensitivity reaction type II disease 2 | 253
Hypothyroidism 2 | 122
Mood Disorders 2 | 184
Pancreatic Neoplasm 2 | 85
Pancreatic Neoplasms 2 | 85
Parkinson's disease 2 | 392
Pediatric failure to thrive 2 | 365
Short nose 2 | 132
Small nose 2 | 132
Vasculitis 2 | 80
Waldenstrons macroglobulinemia 2 | 765
atypical teratoid/rhabdoid tumor 2 | 357

Tissue

Digestive Tract 29 | 17,369
Endocrine System 29 | 18,159
Liver and Pancreas 29 | 16,750
Female tissues 28 | 17,400
Male tissues 27 | 17,142
Respiratory system 27 | 16,393
Skin and soft tissues 27 | 17,230
Blood and immune system 26 | 16,909
Nervous System 26 | 16,725
Urinary Tract 26 | 16,678
Cardiovascular System 24 | 15,192

Target Family

Non-IDG 19 | 12,091
Enzyme 5 | 4,145
Ion Channel 3 | 344
Transcription Factor 3 | 1,400
GPCR 2 | 408
Nuclear Receptor 1 | 48

GO Process

positive regulation of insulin... 33 | 33
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Bile acid receptor NR1H4 Tclin Nuclear Receptor -2.57379 350.3 293
Syntabulin SYBU Tbio Non-IDG -0.98265 12.1 14
Beta-arrestin-1 ARRB1 Tbio Non-IDG -2.63877 418.5 490
Syntaxin-4 STX4 Tbio Non-IDG -1.95295 84.2 207
Cystic fibrosis transmembrane conductance regulator CFTR Tclin Ion Channel -3.79415 6397.4 472
Glucagon GCG Tchem Non-IDG -4.23329 17114.4 1097
DNA-binding protein RFX6 RFX6 Tbio Transcription Factor -2.57722 368.8 44
Anoctamin-1 ANO1 Tclin Ion Channel -2.58674 414.4 565
HLA class II histocompatibility antigen, DRB1-4 beta chain HLA-DRB1 Tbio Non-IDG 0.00000 0
HLA class II histocompatibility antigen, DRB1-7 beta chain HLA-DRB1 Tbio Non-IDG 0.00000 0